Boston Scientific Corporation

Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Boston Scientific released the full $8 million holdback on schedule and with no claimsEscrow release is the third funding catalyst Elutia has delivered in 2026, following the August closings of its Avenue Capital loan facility and SimpliDerm® divestitureThe Company is now fully funded through the first year of the expected NXT-41x launch and into 2029 GAITHERSBURG, Md., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix t

Yahoo Finance · 01/10/2026 · lire l'article ↗

How Big Could BSX Stock's Next Fall Be?

Boston Scientific (BSX) stock has lost more than half its value over the past 12 months, while the S&P 500 returned 18.0%. A subsequent setback occurred in September, when the company said a cyberattack would likely keep it from meeting its guidance. If the wider market turns now, how big could the next fall be, and how long would you wait? The answer depends on how well Boston Scientific is equipped to absorb a broader downturn today.

Yahoo Finance · 28/09/2026 · lire l'article ↗

Why Oppenheimer Cut Boston Scientific’s Price Target by $20 Despite Keeping its Outperform Rating

Oppenheimer has become considerably more cautious on Boston Scientific Corporation (NYSE:BSX), but not cautious enough to abandon its bullish rating. Analyst Suraj Kalia lowered the firm’s price target on Boston Scientific to $65 from $85 on September 21, ahead of the company’s quarterly results, while maintaining an Outperform rating. Kalia is also reducing Oppenheimer’s fiscal […]

Yahoo Finance · 28/09/2026 · lire l'article ↗

Boston Scientific (BSX) Faces A Recall, Is The 28% Undervaluation Still Compelling?

Boston Scientific (BSX) is in focus after initiating a Class II recall of its StoneSmart Connect Console power adapters, affecting 982 units distributed across the US and multiple international markets. Against this recall backdrop, Boston Scientific’s share price has eased 1.7% over the last trading day and is down 6.2% over the past month, while the 1‑year total shareholder return has declined 54.7%, signaling fading momentum despite a small 2.9% gain on a 90‑day share price basis. Scan how...

Yahoo Finance · 28/09/2026 · lire l'article ↗

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Yahoo Finance · 28/09/2026 · lire l'article ↗

What Do Boston Scientific (BSX) Recall And Executive Retirement Mean For Investors?

Boston Scientific (NYSE: BSX) has started a voluntary global recall of its StoneSmart Connect Console over a power adapter safety issue. The company is informing hospitals and healthcare providers worldwide about the recall and advising on identification and return of affected units. Arthur C. Butcher, who oversees key endoscopy and urology portfolios, has notified Boston Scientific of his decision to retire. The recall of StoneSmart Connect and Arthur C. Butcher's retirement only capture...

Yahoo Finance · 28/09/2026 · lire l'article ↗